Last reviewed · How we verify
NCT07127198
Tolerance and Appetite Reduction of a Nutritional Solution With Intragastric Gelation Properties
NA trial testing Beverage Variant 1 (low gelation properties) in Weight Management in 24 participants. Completed in 31 October 2025.
31 October 2025
Quick facts
| Lead sponsor | Société des Produits Nestlé (SPN) |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | other |
| Enrollment | 24 |
| Start date | 22 May 2025 |
| Primary completion | 31 October 2025 |
| Estimated completion | 31 October 2025 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Beverage Variant 1 (low gelation properties)
- Beverage Variant 2 (medium gelation properties)
- Beverage Variant 3 (high gelation properties)
- Control group (no gelation property)
Conditions studied
- Weight Management — all drugs for Weight Management →
Sponsor
Société des Produits Nestlé (SPN) — full company profile →
Who can join
Adults 18 to 65, any sex, with Weight Management. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The physical properties of a food product, such as its gelling properties in the stomach can influence how full a person may feel after its consumption. Decreasing appetite feeling through consumption of such a product with a low energy content may contribute to weight management. The study will assess if a drink with gelation properties in the stomach can reduce appetite and therefore contribute to weight management. This is a single-center, double-blinded, 4 arm cross-over randomized controlled study looking to enroll 24 adult participants. The study will be performed at the Clinical Innovation Lab (CIL), Nestlé Research, Lausanne. Enrolled participants will have 4 visit days after the screening visit. They will consume one of the test products, or control at each visit and complete the study assessments.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07127198
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Weight Management
Currently open trials in the same condition.
- NCT07426952 — Weight Management After Cancer for Survivors in Rural Communities · NA · recruiting
- NCT07272824 — Usability Study of Gestational and Postpartum Weight Management Program · recruiting
- NCT07243171 — A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tab · Phase 1, PHASE2 · recruiting
- NCT07089823 — A Study of YP05002 in Healthy Participants · Phase 1 · recruiting
- NCT07073417 — A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH) · Phase 2 · active not recruiting
Other Société des Produits Nestlé (SPN) trials
Trials by the same sponsor.
- NCT07312201 — Oral Nutritional Supplementation in Children With Growth Concerns · NA · not yet recruiting
- NCT07378111 — Vegetarian Tube Feed Study · NA · not yet recruiting
- NCT07439718 — The Effects of an Oral Nutritional Intervention on the Small Intestine Microbiome · NA · recruiting
- NCT07341464 — Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends · NA · recruiting
- NCT06981468 — Hydration To be Optimized (H2O) With a Low-sodium Beverage · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07127198 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Société des Produits Nestlé (SPN)
- Last refreshed: 19 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07127198.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing